Agronomics Limited, a UK-based investment company, is a leading player in the burgeoning cellular agriculture sector. In 2024, the company made significant strides, investing £13.5 million in precision fermentation technologies and cultivated meat innovations. One notable achievement was Meatly’s development of a protein-free culture medium, which reduces the cost of cultivated meat production. The company also secured regulatory approval for its cultivated chicken for pet food, a crucial step towards commercialization. Despite reporting a net unrealised loss of £8.3 million, Agronomics’ portfolio saw positive revaluations of £6.9 million. The company’s diversified portfolio, comprising 30% precision fermentation, 30% cultivated meat, and 16% Liberation Labs, allows it to tap into different market segments and leverage the faster commercialization timeline of precision fermentation technologies. With its focus on sustainability and innovation, Agronomics is well-positioned to capitalize on the growing demand for sustainable food solutions and alternative proteins, making it a compelling investment opportunity for those seeking exposure to this transformative industry.
Pioneering a New Era in Cellular Agriculture – Cavendish
